Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo

Realizing the full potential of iron oxide nanoparticles (IONP) for cancer diagnosis and therapy requires selective tumor cell accumulation. Here, we report a systematic analysis of two key determinants for IONP homing to human breast cancers: (i) particle size and (ii) active vs passive targeting....

Descripción completa

Detalles Bibliográficos
Autores principales: NDong, Christian, Tate, Jennifer A., Kett, Warren C., Batra, Jaya, Demidenko, Eugene, Lewis, Lionel D., Hoopes, P. Jack, Gerngross, Tillman U., Griswold, Karl E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335054/
https://www.ncbi.nlm.nih.gov/pubmed/25695795
http://dx.doi.org/10.1371/journal.pone.0115636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335054/
https://www.ncbi.nlm.nih.gov/pubmed/25695795
http://dx.doi.org/10.1371/journal.pone.0115636

Ejemplares similares